ARS Investment Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-26,887
| Closed | -$2.67M | – | 167 |
|
|
2023
Q4 | $2.67M | Sell |
26,887
-43,363
| -62% | -$4.31M | 0.3% | 53 |
|
|
2023
Q3 | $7.26M | Sell |
70,250
-1,406
| -2% | -$145K | 0.9% | 34 |
|
|
2023
Q2 | $8.71M | Sell |
71,656
-4,127
| -5% | -$501K | 1.02% | 31 |
|
|
2023
Q1 | $11.6M | Buy |
75,783
+537
| +0.7% | +$82.5K | 1.4% | 25 |
|
|
2022
Q4 | $13.5M | Buy |
75,246
+71,736
| +2,044% | +$12.9M | 1.8% | 20 |
|
|
2022
Q3 | $415K | Buy |
+3,510
| New | +$415K | 0.06% | 108 |
|
|
2021
Q1 | – | Sell |
-3,730
| Closed | -$390K | – | 144 |
|
|
2020
Q4 | $390K | Buy |
3,730
+530
| +17% | +$55.4K | 0.05% | 90 |
|
|
2020
Q3 | $226K | Buy |
+3,200
| New | +$226K | 0.04% | 94 |
|